Subcellular targeting of theranostic radionuclides
The last decade has seen rapid growth in the use of theranostic radionuclides for the treatment and imaging of a wide range of cancers. Radionuclide therapy and imaging rely on a radiolabeled vector to specifically target cancer cells. Radionuclides that emit β particles have thus far dominated the...
Main Authors: | , , , , |
---|---|
Format: | Journal article |
Published: |
Frontiers Media
2018
|